Antileukemic effects of ²¹³Bi-HuM195.

(A) Numbers of circulating blasts before and after treatment. Fourteen (93%) of 15 evaluable patients had reductions in the number of peripheral blood blasts. (B) Percentages of bone marrow blasts before and after treatment are shown for each dose level from 10.36 to 37 MBq/kg. Fourteen (78%) of the 18 patients had reductions in the percentages of bone marrow leukemia cells after 7 to 10 days.